1.66

2.35% -0.04

Alzamend Neuro Inc (ALZN)

Überblick Nachrichten Preisverlauf Financials Warum fällt ALZN? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.70

Offen:

$1.7

24-Stunden-Volumen:

63,177

Relative Volume:

0.47

Marktkapitalisierung:

$7.95M

Einnahmen:

Nettoeinkommen (Verlust:

$-7.04M

KGV:

-0.3791

EPS:

-4.3784

Netto-Cashflow:

$-6.17M

1W Leistung:

+0.00%

1M Leistung:

+14.48%

6M Leistung:

-16.16%

1J Leistung:

-26.87%

1-Tages-Spanne:

$1.65

$1.73

1-Wochen-Bereich:

$1.51

$1.73

52-Wochen-Spanne:

$0.84

$2.68

Alzamend Neuro Inc Stock (ALZN) Company Profile

Firmenname

Alzamend Neuro Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (600)

Telefon

844-722-6333

Adresse

480 PEACHTREE ROAD NE, SECOND FLOOR, ATLANTA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-09-09

Neueste SEC-Einreichungen

ALZN's Discussions on Twitter

Compare ALZN vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALZN Alzamend Neuro Inc	1.66	7.81M	0	-7.04M	-6.17M	-4.3784
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-10-01	Eingeleitet	Ascendiant Capital Markets	Buy

Alzamend Neuro Inc Aktie (ALZN) Neueste Nachrichten

Aug 20, 2026

Alzamend Neuro (ALZN) files amended insider trading report - Stock Titan

Aug 20, 2026

Alzamend’s lithium treatment data accepted for neuroscience meeting - Investing.com

Aug 20, 2026

Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC - PR Newswire

Aug 20, 2026

Aug 19, 2026

Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga

Aug 19, 2026

Aug 18, 2026

Alzamend (ALZN) Results at a Glance: Profit Per Share Clears Its Benchmark on the Day; Post-Earnings Trading - vinanet.vn

Aug 18, 2026

Alzamend to present lithium imaging data at Barcelona workshop By Investing.com - Investing.com Canada

Aug 18, 2026

Alzamend to present lithium imaging data at Barcelona workshop - Investing.com South Africa

Aug 18, 2026

Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain - Investing News Network

Aug 18, 2026

Aug 13, 2026

Alzamend Neuro (ALZN) Advances 2.1% as Shares Hold Above $1.39 SupportDiagonal Spread Trade - vinanet.vn

Aug 13, 2026

Aug 08, 2026

ALZN Q2 2026 Earnings: Narrower-Than-Expected Loss as Clinical Pipeline Remains CentralEarnings Preview - vinanet.vn

Aug 08, 2026

Aug 06, 2026

Alzamend Neuro (ALZN) Drops 3.5% to $1.38 as Shares Approach Key SupportBreak of Structure - dars.gov.et

Aug 06, 2026

Aug 04, 2026

Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending - marketscreener.com

Aug 04, 2026

Alzamend Neuro secures $7.5M in initial funding tranche - Investing.com

Aug 04, 2026

Alzamend Neuro Secures $25 Million Preferred Stock Financing - TipRanks

Aug 04, 2026

Aug 03, 2026

Alzamend Neuro Secures Up to $25 Million Series D Preferred Financing; $7.5 Million Funded - TradingView

Aug 03, 2026

Aug 01, 2026

ALZN Q2 2026 Earnings: Narrower-Than-Expected Loss of -$0.47 Highlights Cost DisciplineEstimate Revision Count - Vinanet

Aug 01, 2026

Jul 28, 2026

Alzamend Neuro’s New Lithium Study Puts AL001 in the Bipolar Disorder Spotlight - TipRanks

Jul 28, 2026

Jul 27, 2026

ALZN|Alzamend Neuro Inc|Price:1.350|Chg%:+0.040 - TradingKey

Jul 27, 2026

Alzamend Neuro Inc reports results for the quarter ended April 30Earnings Summary - TradingView

Jul 27, 2026

TradingKey - TradingKey

Jul 27, 2026